Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Pharma Mar SA (PHMMF)

OTHER OTC:PHMMF

PHMMF

Pharma Mar SA

RESEARCH TOOLSreports

Pharma Mar SA (PHMMF) Ratios

Compare

57 Followers

Pharma Mar SA Ratios

PHMMF's free cash flow for Q4 2025 was €0.94. For the 2025 fiscal year, PHMMF's free cash flow was decreased by € and operating cash flow was €0.45. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	3.02	3.02	3.03	2.63	2.83
Quick Ratio	2.44	2.44	2.41	2.22	2.54
Cash Ratio	0.19	0.19	0.76	0.63	1.54
Solvency Ratio	0.58	0.58	0.23	0.05	0.32
Operating Cash Flow Ratio	0.57	0.57	0.07	-0.14	0.39
Short-Term Operating Cash Flow Coverage	4.82	4.82	0.76	-1.05	2.92
Net Current Asset Value	€ 140.17M	€ 140.17M	€ 108.96M	€ 105.52M	€ 104.88M
Leverage Ratios
Debt-to-Assets Ratio	0.13	0.13	0.15	0.13	0.11
Debt-to-Equity Ratio	0.20	0.20	0.25	0.23	0.19
Debt-to-Capital Ratio	0.16	0.16	0.20	0.18	0.16
Long-Term Debt-to-Capital Ratio	0.12	0.12	0.16	0.12	0.10
Financial Leverage Ratio	1.57	1.57	1.68	1.76	1.76
Debt Service Coverage Ratio	6.33	5.26	3.39	0.61	3.72
Interest Coverage Ratio	31.81	37.85	2.62	-1.58	18.55
Debt to Market Cap	0.03	0.04	0.03	0.05	0.03
Interest Debt Per Share	2.97	2.93	3.05	2.57	2.49
Net Debt to EBITDA	0.48	0.65	-0.57	-3.60	-2.06
Profitability Margins
Gross Profit Margin	92.64%	94.46%	95.32%	93.92%	93.05%
EBIT Margin	25.93%	18.19%	8.27%	-0.76%	23.51%
EBITDA Margin	29.55%	21.81%	12.14%	2.88%	26.52%
Operating Profit Margin	24.93%	18.19%	3.70%	-2.42%	22.45%
Pretax Profit Margin	26.94%	26.94%	6.85%	-2.29%	22.30%
Net Profit Margin	33.87%	33.87%	14.94%	0.72%	25.14%
Continuous Operations Profit Margin	33.87%	33.87%	14.94%	0.72%	25.14%
Net Income Per EBT	125.71%	125.71%	217.98%	-31.38%	112.71%
EBT Per EBIT	108.09%	148.11%	185.30%	94.67%	99.36%
Return on Assets (ROA)	18.98%	18.98%	7.47%	0.33%	12.55%
Return on Equity (ROE)	35.36%	29.78%	12.54%	0.59%	22.14%
Return on Capital Employed (ROCE)	18.32%	13.37%	2.42%	-1.56%	14.89%
Return on Invested Capital (ROIC)	17.58%	12.83%	2.34%	0.46%	14.19%
Return on Tangible Assets	19.15%	19.15%	7.49%	0.34%	12.63%
Earnings Yield	5.21%	5.82%	1.87%	0.15%	4.25%
Efficiency Ratios
Receivables Turnover	3.65	3.65	5.04	5.74	6.70
Payables Turnover	0.30	0.23	0.21	0.33	0.50
Inventory Turnover	0.30	0.23	0.16	0.24	0.49
Fixed Asset Turnover	3.68	3.68	2.96	3.32	5.66
Asset Turnover	0.56	0.56	0.50	0.46	0.50
Working Capital Turnover Ratio	1.29	1.24	1.08	0.95	1.02
Cash Conversion Cycle	94.57	92.82	618.17	447.65	61.31
Days of Sales Outstanding	99.90	99.90	72.39	63.59	54.51
Days of Inventory Outstanding	1.21K	1.61K	2.27K	1.49K	742.52
Days of Payables Outstanding	1.22K	1.62K	1.72K	1.11K	735.73
Operating Cycle	1.31K	1.71K	2.34K	1.56K	797.04
Cash Flow Ratios
Operating Cash Flow Per Share	3.09	3.09	0.34	-0.75	2.12
Free Cash Flow Per Share	2.54	2.54	-0.54	-1.64	1.63
CapEx Per Share	0.54	0.54	0.88	0.89	0.49
Free Cash Flow to Operating Cash Flow	0.82	0.82	-1.57	2.19	0.77
Dividend Paid and CapEx Coverage Ratio	2.28	2.28	0.22	-0.49	1.86
Capital Expenditure Coverage Ratio	5.66	5.66	0.39	-0.84	4.33
Operating Cash Flow Coverage Ratio	1.08	1.08	0.12	-0.31	0.90
Operating Cash Flow to Sales Ratio	0.24	0.24	0.03	-0.09	0.20
Free Cash Flow Yield	3.02%	3.39%	-0.68%	-3.89%	2.54%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	19.21	17.19	53.57	664.68	23.52
Price-to-Sales (P/S) Ratio	6.55	5.82	8.00	4.78	5.91
Price-to-Book (P/B) Ratio	5.72	5.12	6.72	3.91	5.21
Price-to-Free Cash Flow (P/FCF) Ratio	33.14	29.46	-147.59	-25.70	39.38
Price-to-Operating Cash Flow Ratio	27.11	24.26	232.22	-56.21	30.29
Price-to-Earnings Growth (PEG) Ratio	0.15	0.09	0.02	-6.81	-0.50
Price-to-Fair Value	5.72	5.12	6.72	3.91	5.21
Enterprise Value Multiple	22.65	27.34	65.37	162.54	20.23
Enterprise Value	1.48B	1.32B	1.39B	739.38M	1.05B
EV to EBITDA	22.65	27.34	65.37	162.54	20.23
EV to Sales	6.69	5.97	7.93	4.68	5.37
EV to Free Cash Flow	33.86	30.19	-146.31	-25.15	35.75
EV to Operating Cash Flow	27.88	24.86	230.21	-54.99	27.49
Tangible Book Value Per Share	14.43	14.43	11.82	10.70	12.21
Shareholders’ Equity Per Share	14.63	14.63	11.88	10.81	12.35
Tax and Other Ratios
Effective Tax Rate	-0.26	-0.26	-1.18	1.31	-0.13
Revenue Per Share	12.86	12.86	9.97	8.84	10.88
Net Income Per Share	4.36	4.36	1.49	0.06	2.73
Tax Burden	1.26	1.26	2.18	-0.31	1.13
Interest Burden	1.04	1.48	0.83	3.00	0.95
Research & Development to Revenue	0.43	0.43	0.59	0.63	0.43
SG&A to Revenue	0.07	0.00	-0.02	0.12	0.10
Stock-Based Compensation to Revenue	<0.01	0.00	0.00	<0.01	<0.01
Income Quality	0.71	0.71	0.50	-11.83	0.88

Currency in EUR